Loading...

PETS PETMED EXPRESS INC Dividend Policy Changes 8-K Filing

PTMD

PTS

PETMED EXPRESS INC

(PETS)

2025 8-K

Summary

Summary

Leadership Changes

Financial Results Report

Financial Reporting Issues

Management Changes

Nasdaq Compliance Notice

Management Changes

Financial Statements

Earnings Results

Document Correction

Rights Agreement

Q2 Earnings Report

Incentive Plan Adoption

CFO Appointment

Approval of Incentive Plan ...

Results of Operations and F...

Appointment of Officer

Appointment of Director

Departure of Directors or C...

Appointment of Director

Management Changes

Results of Operations and F...

Notice of Delisting

Financial Results

Appointment of Chairman

Results of Operations and F...

Annual Meeting of Shareholders

Results of Operations and F...

Amendment and Restatement o...

Earnings Reports

Appointment of New Director...

Acquisition of PetCareRx Inc

Financial Results and Divid...

Merger of Equals

Merger Agreement

External Links:

On October 1, 2025, PetMed Express Inc. disclosed a $1.2 million impairment of its PCRX trade name and indicated that its prior financial statements for March 31, 2023, and March 31, 2024, are unreliable due to errors in revenue reporting, with corrections expected in the upcoming report.

AI Assistant

PETMED EXPRESS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.